Neurologist. Comprehensive Stroke Center. Hospital Clínico Universitario. Professor of Neurology, Universidad de Valladolid
Valladolid, Spain
Joined December 2011
- Tweets1.6K
- Following572
- Followers1.9K
- Likes1.1K
Pinned Tweet
Un sueño hecho realidad - A dream come true. HCU Valladolid 2008-2021, from first tPA-treated patient to @ESOstroke #Stroke Centre. Thank you to all who have helped make this possible! Gracias y enhorabuena a tod@s!
Juan F. Arenillas retweeted
La leucemia es una enfermedad grave que afecta a niños y jóvenes de todo el mundo
Sólo 1/4 de los pacientes que necesitan un trasplante tienen un familiar compatible. En estos casos un donante compatible fuera de la familia, es su única esperanza 🧵👇
youtu.be/QlsTCSCHCPs
Juan F. Arenillas retweeted
Check out the article, "Sex-Stratified Genome-Wide Association Study in the Spanish Population Identifies a Novel Locus for Lacunar Stroke" ⬇️
ahajournals.org/doi/full/10.…
#AHAJournals @ArenillasJF @brainbleedmd @FabregaGallego @MarFreijo @JaraCarcel @vobach3 @israelcadenas1
Hoy celebramos el #diamundialdelictus, con nuestro apoyo y recuerdo para pacientes y familiares, poniendo el foco en la prevención desde las edades más jóvenes
Juan F. Arenillas retweeted
Día Internacional del Daño Cerebral Adquirido 🧠💡
Investigamos nuevas tecnologías para mejorar la rehabilitación de quienes sufren Daño Cerebral Adquirido (DCA)
#DañoCerebral #Rehabilitación #Investigación #DíaDañoCerebralAdquirido
Juan F. Arenillas retweeted
Compartimos nuestra reciente publicación: "A systematic review of the socioeconomic impact of mechanical thrombectomy for acute ischemic stroke".
Gracias a todo el equipo 🔎
sciencedirect.com/science/ar…
Enhorabuena a tod@s los pucelan@s por el ascenso!! #PucelaEsDePrimera
Gracias @realvalladolid, gracias @papapezzoIano, obrigado @Ronaldo
Juan F. Arenillas retweeted
🏃 Over 160 delegates at #ESOC2024 laced up their running shoes bright and early at 7:00 CEST for the Stroke Run! What a fantastic start to the day, promoting health and #stroke awareness among our community and beyond.
#StrokeAwareness #StrokeResearch #StrokeScience
Enhorabuena @pamuca84 un lujo tenerte en el Servicio! 🙌🏼🙌🏼🙌🏼@NeurologiaHCUV
Juan F. Arenillas retweeted
sen.es/noticias-y-actividade… – at Valladolid, Spain
Juan F. Arenillas retweeted
Now two stentretrievers required⁉️Twin2Win RCT, stopped early, shows superiority for reperfusion! #ISC24 Great study from@marcriboj @esmintsociety @DGNR_org
Juan F. Arenillas retweeted
In US hospitals participating in Get With The Guidelines–Stroke, earlier anticoagulation reversal was associated with improved survival for patients with intracerebral hemorrhage. ja.ma/4brb2r3 #ISC24
Juan F. Arenillas retweeted
3 RCT all showing MMA embolization superior to standard of care for treatment of #SDH. A new era for treatment. #ISC24
Juan F. Arenillas retweeted
TIMELESS trial: Tenecteplase for thrombolysis in a 4.5-to-24-hour window did not improve disability outcomes at 90 days in patients with ischemic stroke who had been chosen on the basis of imaging. Most patients had endovascular thrombectomy. nej.md/3wa2tAR #ISC24
Juan F. Arenillas retweeted
Endovascular thrombectomy, vs medical management, improved clinical outcomes across a wide spectrum of ischemic core volumes and penumbral profiles; however, large ischemic core volume is an important prognostic factor in treatment decisions.
#ISC24
ja.ma/49tfbbZ
Juan F. Arenillas retweeted
In patients with cryptogenic stroke and evidence of atrial cardiopathy without atrial fibrillation, apixaban did not significantly reduce recurrent stroke risk compared with aspirin.
#ISC24
ja.ma/3Us1vde
Juan F. Arenillas retweeted
@SELECT2Trial EVT improved outcomes across ASPECTS and core volumes strata, in those with/without mismatch. Composite core volumes correlated best with outcomes. CTP overestimation was infrequent(<1%). Reduced infarct growth with mTICI≥2b and mRS 0-2/0-3 jamanetwork.com/journals/jam…
Juan F. Arenillas retweeted
Exciting news! aptaTargets receives €4M from the @CienciaGob for the Phase 2b clinical trial with #ApTOLL in patients with #AcuteIchemicStroke: bit.ly/48G6xqV
The consortium is formed by @idibell_cat @GTRecerca @UVa_es and @VHIR_.
